| scholarly article | Q13442814 |
| P50 | author | Andreas Diefenbach | Q56954454 |
| P2093 | author name string | Carl F Ware | |
| Robert Thimme | |||
| Cedric Vonarbourg | |||
| Daniela Finke | |||
| Elina A Kiss | |||
| Klaus Schwarz | |||
| Ulrich Pannicke | |||
| Manfred Hönig | |||
| Bertram Bengsch | |||
| Arthur Mortha | |||
| Viet L Bui | |||
| Christoph Hölscher | |||
| Melanie Flach | |||
| Pedro P Hernandez | |||
| Thomas Hoyler | |||
| P2860 | cites work | Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency | Q22008480 |
| Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 | Q24290619 | ||
| Systemically dispersed innate IL-13-expressing cells in type 2 immunity | Q24623563 | ||
| Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity | Q24630261 | ||
| Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 | Q24648620 | ||
| Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22 | Q24655076 | ||
| Interleukin-23 drives innate and T cell-mediated intestinal inflammation | Q24677051 | ||
| Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus | Q24797230 | ||
| Requirement for RORgamma in thymocyte survival and lymphoid organ development | Q28139666 | ||
| An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells | Q28235728 | ||
| A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 | ||
| Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells | Q28271481 | ||
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
| Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development | Q28585776 | ||
| Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice | Q28594052 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| NK cell recognition | Q29615107 | ||
| Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
| IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors | Q33656197 | ||
| Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. | Q33854381 | ||
| Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity | Q33934522 | ||
| RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells | Q34441341 | ||
| Intestinal lamina propria dendritic cell subsets have different origin and functions. | Q35001346 | ||
| The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. | Q35002543 | ||
| Evidence for discrete stages of human natural killer cell differentiation in vivo | Q36228536 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. | Q37362415 | ||
| Hidden talents of natural killers: NK cells in innate and adaptive immunity | Q37381928 | ||
| Regulatory lymphocytes and intestinal inflammation. | Q37419380 | ||
| Late developmental plasticity in the T helper 17 lineage | Q39265291 | ||
| Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease | Q39902875 | ||
| Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. | Q41904687 | ||
| Origin of the lamina propria dendritic cell network | Q42117974 | ||
| Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin | Q42604162 | ||
| Isolation of NK cells and NK-like cells from the intestinal lamina propria | Q43771245 | ||
| Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells. | Q45918490 | ||
| Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
| Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells | Q46231038 | ||
| Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. | Q46461994 | ||
| Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. | Q51985115 | ||
| Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. | Q52586488 | ||
| Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. | Q52590127 | ||
| The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes. | Q52599046 | ||
| Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. | Q53590422 | ||
| Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. | Q54652657 | ||
| A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 | Q58478714 | ||
| Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells | Q73838320 | ||
| Innate lymphocytes induce inflammatory bowel disease | Q84494196 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 736-751 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes | |
| P478 | volume | 33 |
| Q36970818 | A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets |
| Q43905966 | A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells |
| Q48231667 | A catch-22: Interleukin-22 and cancer |
| Q90494825 | A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut |
| Q92437547 | A hierarchical role of IL-25 in ILC development and function at the lung mucosae following viral-vector vaccination |
| Q38426867 | A network of high-mobility group box transcription factors programs innate interleukin-17 production |
| Q36309139 | AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch |
| Q34287702 | Action of RORs and their ligands in (patho)physiology. |
| Q92265844 | Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation |
| Q90628227 | Acute cellular rejection in small-bowel transplantation impairs NCR+ innate lymphoid cell subpopulation 3/interleukin 22 axis |
| Q38964535 | An in vitro model of innate lymphoid cell function and differentiation. |
| Q38233854 | An overview of the role of innate lymphoid cells in gut infections and inflammation |
| Q33567987 | Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin |
| Q34969719 | Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation |
| Q26853011 | Aryl hydrocarbon receptor: a molecular link between postnatal lymphoid follicle formation and diet |
| Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
| Q37866633 | Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. |
| Q96952258 | Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity |
| Q41668932 | CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells |
| Q42258575 | CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen |
| Q102211064 | Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion |
| Q91663496 | Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells |
| Q39193836 | Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15. |
| Q90494861 | Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells |
| Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
| Q34502663 | Complementarity and redundancy of IL-22-producing innate lymphoid cells. |
| Q36116749 | Composition, Development, and Function of Uterine Innate Lymphoid Cells |
| Q35006085 | Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome |
| Q41323743 | Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNFα, induces robust activation and a phenotypic switch of ILC3. |
| Q37851543 | Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells |
| Q39256177 | Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease |
| Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
| Q28077126 | Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment |
| Q35597581 | Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice. |
| Q50527654 | Cutting Edge: Innate Lymphoid Cells Suppress Homeostatic T Cell Expansion in Neonatal Mice. |
| Q40361007 | Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells. |
| Q50317364 | Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells. |
| Q34055620 | DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCs |
| Q90733032 | Dazed and Confused: NK Cells |
| Q51739535 | Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis. |
| Q64079803 | Deciphering the Roles of Innate Lymphoid Cells in Cancer |
| Q26861554 | Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time |
| Q57181208 | Deconstructing deployment of the innate immune lymphocyte army for barrier homeostasis and protection |
| Q37968301 | Development and evolution of RORγt+ cells in a microbe's world |
| Q36711845 | Development and maturation of natural killer cells |
| Q38252608 | Development, differentiation, and diversity of innate lymphoid cells |
| Q38046108 | Dietary influences on intestinal immunity |
| Q38582546 | Differentiation and diversity of subsets in group 1 innate lymphoid cells |
| Q38587657 | Differentiation and function of group 3 innate lymphoid cells, from embryo to adult |
| Q49205651 | Divergent Roles of Interferon-γ and Innate Lymphoid Cells in Innate and Adaptive Immune Cell-Mediated Intestinal Inflammation. |
| Q88538287 | Diverse developmental pathways of intestinal intraepithelial lymphocytes |
| Q34700661 | Diverse roles of inhibitor of differentiation 2 in adaptive immunity |
| Q36693141 | Diversity, function, and transcriptional regulation of gut innate lymphocytes |
| Q40241853 | Do the Microbiota Influence Vaccines and Protective Immunity to Pathogens? Engaging Our Endogenous Adjuvants |
| Q28075218 | Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease |
| Q41990559 | Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency |
| Q37346684 | Emerging concepts and future challenges in innate lymphoid cell biology |
| Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
| Q33874975 | Establishment and function of tissue-resident innate lymphoid cells in the skin |
| Q35546855 | Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor |
| Q64271793 | Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells |
| Q35916424 | Flt3 Ligand Regulates the Development of Innate Lymphoid Cells in Fetal and Adult Mice. |
| Q38213433 | From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells. |
| Q41838358 | Functional Differences between Human NKp44(-) and NKp44(+) RORC(+) Innate Lymphoid Cells |
| Q39034173 | Functional and phenotypic heterogeneity of group 3 innate lymphoid cells |
| Q92215594 | Functional interactions between innate lymphoid cells and adaptive immunity |
| Q87994387 | Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation |
| Q47095720 | Group 2 Innate Lymphoid Cells Exhibit a Dynamic Phenotype in Allergic Airway Inflammation |
| Q38122453 | Group 2 innate lymphoid cells in lung inflammation |
| Q64071688 | Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! |
| Q47138366 | Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System |
| Q28081074 | Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice |
| Q37448373 | Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. |
| Q38602944 | Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer |
| Q39167526 | Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung |
| Q41918189 | Guidelines for the use of flow cytometry and cell sorting in immunological studies |
| Q37867487 | Harnessing the biology of IL-7 for therapeutic application |
| Q34467203 | Heterogeneity across the murine small and large intestine |
| Q38606216 | Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block |
| Q41911216 | HiJAKing Innate Lymphoid Cells? |
| Q36351062 | Homeostatic Immunity and the Microbiota |
| Q36157411 | Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome. |
| Q33814843 | How implementation of systems biology into clinical trials accelerates understanding of diseases. |
| Q37397482 | Human CD4+CD3- innate-like T cells provide a source of TNF and lymphotoxin-αβ and are elevated in rheumatoid arthritis |
| Q84933191 | Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 |
| Q90290778 | Human NK Cell Development: One Road or Many? |
| Q85926211 | Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues |
| Q34157945 | ID'ing innate and innate-like lymphoid cells |
| Q97519137 | IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology |
| Q36767462 | IL-12 drives functional plasticity of human group 2 innate lymphoid cells |
| Q37737853 | IL-15 sustains IL-7R-independent ILC2 and ILC3 development |
| Q53071524 | IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival. |
| Q38040743 | IL-17-producing γδ T cells and innate lymphoid cells |
| Q53793238 | IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. |
| Q33971114 | IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease |
| Q36474946 | IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice |
| Q34693462 | IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis. |
| Q53360318 | IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. |
| Q41964089 | IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. |
| Q37325464 | IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism |
| Q37994026 | IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time |
| Q26752285 | ILC1s in Tissue Inflammation and Infection |
| Q36520874 | ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation |
| Q90608632 | ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients |
| Q64066256 | ILC3 function as a double-edged sword in inflammatory bowel diseases |
| Q34979643 | Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine |
| Q35177247 | Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells |
| Q90732984 | Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock |
| Q39000249 | Immune modules shared by innate lymphoid cells and T cells |
| Q50042967 | Immunological pathogenesis of inflammatory bowel disease. |
| Q27027636 | Immunopathology of inflammatory bowel disease |
| Q38004933 | Immunoregulation by the gut microbiota |
| Q89965683 | Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis |
| Q37693528 | Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs |
| Q38539813 | Influence of nutrient-derived metabolites on lymphocyte immunity |
| Q38124101 | Inhibition of IL-17 as a pharmacological approach for IBD. |
| Q37354974 | Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis |
| Q50228830 | Innate Lymphoid Cell Immunometabolism. |
| Q47162429 | Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules |
| Q49920496 | Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis. |
| Q35611711 | Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. |
| Q50165380 | Innate Lymphoid Cells Mediate Pulmonary Eosinophilic Inflammation, Airway Mucous Cell Metaplasia, and Type 2 Immunity in Mice Exposed to Ozone. |
| Q90092769 | Innate Lymphoid Cells at the Maternal-Fetal Interface in Human Pregnancy |
| Q64058682 | Innate Lymphoid Cells in Helminth Infections-Obligatory or Accessory? |
| Q53796096 | Innate Lymphoid Cells in Tumor Immunity. |
| Q58707784 | Innate Lymphoid Cells in the Maternal and Fetal Compartments |
| Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
| Q89167818 | Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity |
| Q88792583 | Innate Recognition of the Microbiota by TLR1 Promotes Epithelial Homeostasis and Prevents Chronic Inflammation |
| Q48316500 | Innate immune cells for immunotherapy of autoimmune and cancer disorders. |
| Q27002611 | Innate immune signaling in defense against intestinal microbes |
| Q36390314 | Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease |
| Q62733580 | Innate lymphoid cell sensing of tissue vitality |
| Q49980468 | Innate lymphoid cells and allergic disease. |
| Q38712079 | Innate lymphoid cells and the MHC. |
| Q34895926 | Innate lymphoid cells and the skin |
| Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
| Q94591730 | Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity |
| Q52641247 | Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. |
| Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
| Q38810910 | Innate lymphoid cells in secondary lymphoid organs |
| Q38165175 | Innate lymphoid cells in the defense against infections |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q27023221 | Innate lymphoid cells in the skin |
| Q40063411 | Innate lymphoid cells in tissue homeostasis and diseases |
| Q37734578 | Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. |
| Q38325566 | Innate lymphoid cells involve in tumorigenesis. |
| Q27026229 | Innate lymphoid cells, possible interaction with microbiota |
| Q29617431 | Innate lymphoid cells--a proposal for uniform nomenclature |
| Q38071916 | Innate lymphoid cells--how did we miss them? |
| Q35638915 | Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology |
| Q36645149 | Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. |
| Q38077406 | Innate lymphoid cells: from border protection to the initiation of inflammatory diseases |
| Q38643190 | Innate lymphoid cells: major players in inflammatory diseases |
| Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
| Q52654737 | Innate-like CD8+ T-cells and NK cells: converging functions and phenotypes. |
| Q34397537 | Interactions between the intestinal microbiota and innate lymphoid cells. |
| Q27028155 | Interactions between the microbiota and the immune system |
| Q38183649 | Interleukin 23 in Crohn's disease |
| Q38102578 | Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia |
| Q26770224 | Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease |
| Q35530956 | Interleukin-22: immunobiology and pathology |
| Q92538732 | Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker |
| Q34182101 | Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis |
| Q58619639 | Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells |
| Q48151041 | Interplay of innate lymphoid cells and the microbiota. |
| Q27331792 | Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice |
| Q38190874 | Intestinal epithelial cells: regulators of barrier function and immune homeostasis |
| Q40381607 | Isolation and Flow Cytometry Analysis of Innate Lymphoid Cells from the Intestinal Lamina Propria |
| Q57181210 | JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians |
| Q98222237 | Keeping time in group 3 innate lymphoid cells |
| Q57099305 | LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection |
| Q60146881 | Lacrimal Gland NK Cells Are Developmentally and Functionally Similar to Conventional NK Cells |
| Q39217244 | Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells |
| Q89551915 | Living with Yourself: Innate Lymphoid Cell Immunometabolism |
| Q51017443 | Long-term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation. |
| Q49896661 | Lymphoid tissue inducer-A divergent member of the ILC family. |
| Q36031510 | Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. |
| Q37722321 | Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells |
| Q38092570 | Lymphotoxin signalling in immune homeostasis and the control of microorganisms. |
| Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
| Q37921196 | Mechanisms of NK cell activation: CD4(+) T cells enter the scene. |
| Q34918999 | Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. |
| Q33822367 | Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches |
| Q37721588 | Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells |
| Q42699781 | Modulation of Signal Strength Switches Notch from an Inducer of T Cells to an Inducer of ILC2. |
| Q35235355 | Modulation of immune development and function by intestinal microbiota. |
| Q35558518 | Mucosal Immune Development in Early Life: Setting the Stage |
| Q38833469 | NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. |
| Q88013801 | NCR+ ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice |
| Q98177647 | NK Cell Development in Times of Innate Lymphoid Cell Diversity |
| Q91496890 | NK cell recruitment limits tissue damage during an enteric helminth infection |
| Q38872138 | NK cells and type 1 innate lymphoid cells: partners in host defense |
| Q54354716 | NK cells can generate from precursors in the adult human liver. |
| Q35858827 | NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine. |
| Q37145726 | NKp80 Defines a Critical Step during Human Natural Killer Cell Development |
| Q64979096 | Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. |
| Q36701917 | Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. |
| Q37568931 | Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity |
| Q37929639 | Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells |
| Q38075724 | New friendships and old feuds: relationships between innate lymphoid cells and microbial communities |
| Q39798251 | Notch signaling in group 3 innate lymphoid cells modulates their plasticity |
| Q51854388 | Notch signaling is necessary for adult, but not fetal, development of RORγt(+) innate lymphoid cells. |
| Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
| Q36750759 | Organ-specific features of natural killer cells |
| Q49283880 | Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation. |
| Q46525184 | Ozone-Induced Nasal Type 2 Immunity in Mice Is Dependent on Innate Lymphoid Cells. |
| Q53411910 | Ozone-Induced Type 2 Immunity in Nasal Airways. Development and Lymphoid Cell Dependence in Mice. |
| Q47897160 | Pathological and therapeutic roles of innate lymphoid cells in diverse diseases |
| Q33899365 | Perfluorooctane sulfonate affects intestinal immunity against bacterial infection |
| Q46547710 | Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells |
| Q39441262 | Plastic Heterogeneity of Innate Lymphoid Cells in Cancer |
| Q89927095 | Plasticity of innate lymphoid cell subsets |
| Q92293401 | Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow |
| Q92852963 | Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells |
| Q91142624 | Pulmonary group 2 innate lymphoid cells: surprises and challenges |
| Q36724677 | RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus |
| Q37987044 | RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation |
| Q52611794 | Re(de)fining Innate Lymphocyte Lineages in the Face of Cancer. |
| Q35012024 | Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation |
| Q38205440 | Recognition strategies of group 3 innate lymphoid cells |
| Q34439411 | Regional specialization within the intestinal immune system |
| Q49544001 | Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. |
| Q34081391 | Regulation of intestinal health and disease by innate lymphoid cells |
| Q37716899 | Regulation of the immune system by the resident intestinal bacteria. |
| Q35880427 | Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. |
| Q39144086 | Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease? |
| Q38927415 | Role of AhR in positive regulation of cell proliferation and survival |
| Q42150907 | Role of innate lymphocytes in infection and inflammation |
| Q34764304 | Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in Salmonella infection |
| Q38016151 | Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes |
| Q36588140 | Role of the gut microbiota in the development and function of lymphoid cells. |
| Q37926818 | Rorγt+ innate lymphoid cells in intestinal homeostasis and immunity |
| Q50095337 | Shaping Innate Lymphoid Cell Diversity. |
| Q91631661 | Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity |
| Q36097460 | Spectral Cytometry Has Unique Properties Allowing Multicolor Analysis of Cell Suspensions Isolated from Solid Tissues |
| Q38239869 | Staying innate: transcription factor maintenance of innate lymphoid cell identity. |
| Q41761867 | Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cells |
| Q92826964 | Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues |
| Q47914100 | Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice |
| Q35156077 | T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. |
| Q33645561 | T cell factor 1 is required for group 2 innate lymphoid cell generation |
| Q100958904 | T cell regeneration after immunological injury |
| Q98288792 | T-bet Expression in Peripheral Th17.0 Cells Is Associated With Pulmonary Function Changes in Sarcoidosis |
| Q37630226 | T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow |
| Q52855961 | T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis. |
| Q38151473 | T-bet: a bridge between innate and adaptive immunity. |
| Q92480505 | TGF-β induces ST2 and programs ILC2 development |
| Q92615075 | Targeting natural killer cells in solid tumors |
| Q42375565 | Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease |
| Q38081172 | Th1- and Th2-like subsets of innate lymphoid cells |
| Q37559676 | The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway |
| Q91451009 | The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis |
| Q35641191 | The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection |
| Q92239566 | The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease |
| Q92538718 | The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment |
| Q42321105 | The LTi cell, an immunologic chameleon |
| Q26778082 | The Role of TOX in the Development of Innate Lymphoid Cells |
| Q35713322 | The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells |
| Q38319907 | The biology of innate lymphoid cells |
| Q97530878 | The interplay between innate lymphoid cells and T cells |
| Q34129422 | The interplay between the gut microbiota and the immune system |
| Q26740079 | The origin and role of innate lymphoid cells in the lung |
| Q89665184 | The role of innate lymphoid cells in response to microbes at mucosal surfaces |
| Q89282567 | The roles for innate lymphoid cells in the human immune system |
| Q42262891 | The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. |
| Q40990833 | The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. |
| Q33634144 | The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells |
| Q24563655 | The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway |
| Q36518480 | The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. |
| Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
| Q45004480 | Thy1+ Sca1+ innate lymphoid cells infiltrate the CNS during autoimmune inflammation, but do not contribute to disease development |
| Q48143276 | Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs |
| Q36482689 | Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs |
| Q50133227 | Tissue-Resident Cytolytic Innate Lymphocytes in Cancer. |
| Q92572255 | Tissue-resident cytotoxic innate lymphoid cells in tumor immunosurveillance |
| Q37684372 | Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells |
| Q35694098 | Tissue-resident natural killer cells and their potential diversity |
| Q38089253 | Tissue-specific effector functions of innate lymphoid cells. |
| Q24629126 | Transcription factor RORα is critical for nuocyte development |
| Q52874734 | Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis. |
| Q38192561 | Transcription factors controlling development and function of innate lymphoid cells |
| Q35064355 | Transcriptional and epigenetic networks of helper T and innate lymphoid cells. |
| Q38525099 | Transcriptional regulation of innate lymphoid cell fate. |
| Q33799561 | Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. |
| Q40689375 | Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells. |
| Q28829881 | Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells |
| Q90000019 | True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity |
| Q35245316 | Tumor necrosis factor superfamily in innate immunity and inflammation |
| Q36180686 | Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation |
| Q38218882 | Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin |
| Q39763196 | Vitamin A Controls the Presence of RORγ+ Innate Lymphoid Cells and Lymphoid Tissue in the Small Intestine |
| Q89167812 | Why Innate Lymphoid Cells? |
| Q37486151 | Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity |
| Q41348746 | Zbtb1 controls NKp46+ ROR-gamma-T+ innate lymphoid cell (ILC3) development |
| Q50673833 | [Innate lymphoid cells: new players of the mucosal immune response]. |
| Q52765682 | [Innate lymphoid cells]. |
| Q90388552 | c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program |
| Q89625928 | c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells |
Search more.